Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer

Poelgeest, M.I.E. van; Visconti, V.V.; Aghai, Z.; Ham, V.J. van; Heusinkveld, M.; Zandvliet, M.L.; ... ; Welters, M.J.P. (2016)

Article / Letter to editor

• Human papillomavirus
• Tumor-draining lymph node
• Cervical cancer
• Adoptive cell transfer
• HPV-specific T cells
• Good manufacturing practice

• All authors: Poelgeest, M.I.E. van; Visconti, V.V.; Aghai, Z.; Ham, V.J. van; Heusinkveld, M.; Zandvliet, M.L.; Valentijn, A.R.P.M.; Goedemans, R.; Minne, C.E. van der; Verdegaal, E.M.E.; Trimbos, J.B.M.Z.; Burg, S.H. van der; Welters, M.J.P.
• Date: 2016-12-31
• Journal: Cancer Immunology, Immunotherapy
• Volume: 65
• Issue: 12
• Pages: 1451 - 1463
• DOI: doi:10.1007/s00262-016-1892-8